JPWO2020010254A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020010254A5 JPWO2020010254A5 JP2021521941A JP2021521941A JPWO2020010254A5 JP WO2020010254 A5 JPWO2020010254 A5 JP WO2020010254A5 JP 2021521941 A JP2021521941 A JP 2021521941A JP 2021521941 A JP2021521941 A JP 2021521941A JP WO2020010254 A5 JPWO2020010254 A5 JP WO2020010254A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- antibody
- subject
- ibd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862693798P | 2018-07-03 | 2018-07-03 | |
| US62/693,798 | 2018-07-03 | ||
| PCT/US2019/040601 WO2020010254A1 (en) | 2018-07-03 | 2019-07-03 | Compositions and methods for treating inflammatory bowel disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021529828A JP2021529828A (ja) | 2021-11-04 |
| JP2021529828A5 JP2021529828A5 (https=) | 2022-07-11 |
| JPWO2020010254A5 true JPWO2020010254A5 (https=) | 2022-07-11 |
Family
ID=69059935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521941A Pending JP2021529828A (ja) | 2018-07-03 | 2019-07-03 | 炎症性腸疾患を治療するための組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210261651A1 (https=) |
| EP (1) | EP3817771A4 (https=) |
| JP (1) | JP2021529828A (https=) |
| KR (1) | KR20210029217A (https=) |
| CN (1) | CN112739376A (https=) |
| AU (1) | AU2019297455A1 (https=) |
| BR (1) | BR112021000025A2 (https=) |
| CA (1) | CA3104402A1 (https=) |
| IL (1) | IL279859A (https=) |
| MX (1) | MX2021000069A (https=) |
| SG (1) | SG11202012774TA (https=) |
| WO (1) | WO2020010254A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116209750A (zh) * | 2019-12-20 | 2023-06-02 | 西奈山伊坎医学院 | 用于治疗炎症性肠病的组合物和方法 |
| TW202227394A (zh) * | 2020-09-11 | 2022-07-16 | 美商工匠生物科技股份有限公司 | 細菌毒素之小分子抑制劑 |
| KR102478205B1 (ko) * | 2020-09-24 | 2022-12-15 | 경희대학교 산학협력단 | 크론병 환자에서 상부위장관 침범 진단을 위한 정보 제공 방법 |
| CN114409777B (zh) * | 2022-01-20 | 2023-09-01 | 温玉荣 | 结直肠癌相关脆弱拟杆菌毒素蛋白激活体的特异性纳米抗体Nb3.27及其应用 |
| CN121285383A (zh) * | 2023-02-21 | 2026-01-06 | 萨尔维图斯公司 | 重组噬菌体、益生菌疫苗和治疗剂、相关组合物以及使用方法 |
| CN116410324A (zh) * | 2023-05-24 | 2023-07-11 | 西安交通大学医学院第一附属医院 | 一种肠道微生物脆弱拟杆菌毒素中和纳米抗体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7090973B1 (en) * | 1999-04-09 | 2006-08-15 | Oscient Pharmaceuticals Corporation | Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics |
| EP2414546A4 (en) * | 2009-04-02 | 2013-03-13 | Univ Johns Hopkins | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF INFLAMMATORY DISEASE AND COLON CARCINOMA |
| CN102939391A (zh) * | 2010-03-01 | 2013-02-20 | 国家农艺研究院 | 炎症性肠病的诊断方法 |
| NZ702796A (en) * | 2010-07-26 | 2017-03-31 | Qu Biologics Inc | Immunogenic anti-inflammatory compositions |
| CN105434476B (zh) * | 2015-10-29 | 2019-02-15 | 广州知易生物科技有限公司 | 一种脆弱拟杆菌在预防和/或治疗炎症性肠病中的应用 |
-
2019
- 2019-07-03 AU AU2019297455A patent/AU2019297455A1/en not_active Abandoned
- 2019-07-03 MX MX2021000069A patent/MX2021000069A/es unknown
- 2019-07-03 US US17/253,333 patent/US20210261651A1/en not_active Abandoned
- 2019-07-03 BR BR112021000025-9A patent/BR112021000025A2/pt not_active IP Right Cessation
- 2019-07-03 KR KR1020217003115A patent/KR20210029217A/ko not_active Ceased
- 2019-07-03 CN CN201980049881.7A patent/CN112739376A/zh active Pending
- 2019-07-03 SG SG11202012774TA patent/SG11202012774TA/en unknown
- 2019-07-03 WO PCT/US2019/040601 patent/WO2020010254A1/en not_active Ceased
- 2019-07-03 CA CA3104402A patent/CA3104402A1/en active Pending
- 2019-07-03 JP JP2021521941A patent/JP2021529828A/ja active Pending
- 2019-07-03 EP EP19829829.1A patent/EP3817771A4/en not_active Withdrawn
-
2020
- 2020-12-30 IL IL279859A patent/IL279859A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021529828A5 (https=) | ||
| Butler et al. | Immunomodulation therapy offers new molecular strategies to treat UTI | |
| Hill et al. | Gonorrhea-an evolving disease of the new millennium | |
| Cunningham | Pathogenesis of group A streptococcal infections and their sequelae | |
| Nguyen et al. | Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons | |
| US11001625B2 (en) | VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor | |
| Barron | Kawasaki disease: etiology, pathogenesis, and treatment | |
| JP2012515551A5 (https=) | ||
| RU2013141134A (ru) | Антитела, которые специфично связывают альфа-токсин staphylococcus aureus, и способы их применения | |
| JPWO2020010254A5 (https=) | ||
| JP2009536818A5 (https=) | ||
| Zhang et al. | The molecular characterization and immune protection of adhesion protein 65 (AP65) of Trichomonas vaginalis | |
| Chatzipanagiotou et al. | Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis | |
| Milford et al. | New insights into the haemolytic uraemic syndromes | |
| JPWO2009005040A1 (ja) | 緑膿菌の外膜タンパク質ｐａ４７１０ | |
| JP2008532931A5 (https=) | ||
| JP2012522522A5 (https=) | ||
| CN101730545A (zh) | 用于治疗肾病的化合物和方法 | |
| Tiels et al. | Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA | |
| US20140271701A1 (en) | Use of mycobacterium avium paratuberculosis peptides to diagnose type 1 diabetes | |
| Twigg III et al. | HIV-related lung disorders | |
| Ding et al. | OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa | |
| Vučković et al. | Host resistance to primary and secondary Campylobacter jejuni infections in C57Bl/6 mice | |
| US12210017B2 (en) | Peptides representing epitopes from filoviruses | |
| Elshina et al. | Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease |